Total Payments
$8,417
2024 Payments
$374.12
Companies
35
Transactions
374
Medicare Patients
26
Medicare Billing
$5,928
Payment Breakdown by Category
Food & Beverage$8,343 (99.1%)
Education$73.64 (0.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,343 | 370 | 99.1% |
| Education | $73.64 | 4 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,120 | 41 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $851.66 | 39 | $0 (2024) |
| ABBVIE INC. | $698.15 | 32 | $0 (2024) |
| UCB, Inc. | $633.03 | 34 | $0 (2024) |
| Radius Health, Inc. | $615.17 | 22 | $0 (2023) |
| Lilly USA, LLC | $520.83 | 24 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $344.98 | 15 | $0 (2019) |
| Mallinckrodt Enterprises LLC | $312.06 | 21 | $0 (2019) |
| Genentech USA, Inc. | $298.98 | 20 | $0 (2018) |
| GlaxoSmithKline, LLC. | $296.80 | 15 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $374.12 | 12 | Amgen Inc. ($128.95) |
| 2023 | $526.25 | 25 | UCB, Inc. ($124.98) |
| 2022 | $570.90 | 22 | Amgen Inc. ($184.78) |
| 2021 | $20.82 | 1 | AbbVie Inc. ($20.82) |
| 2019 | $834.21 | 32 | Radius Health, Inc. ($241.24) |
| 2018 | $3,406 | 164 | Novartis Pharmaceuticals Corporation ($623.06) |
| 2017 | $2,684 | 118 | AbbVie, Inc. ($354.26) |
All Payment Transactions
374 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $124.92 | General |
| 12/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/24/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: Dermatology | ||||||
| 08/27/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: Bone Health | ||||||
| 07/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.26 | General |
| Category: IMMUNOLOGY | ||||||
| 06/25/2024 | Fresenius Kabi USA, LLC | IDACIO (Biological) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Biosimilars | ||||||
| 05/22/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/20/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $31.94 | General |
| Category: Immunology | ||||||
| 03/18/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Bone Health | ||||||
| 02/20/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/19/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Bone Health | ||||||
| 12/14/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: KRYSTEXXA | ||||||
| 11/29/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Dermatology | ||||||
| 11/14/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Bone Health | ||||||
| 10/25/2023 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Endocrinology | ||||||
| 10/18/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Dermatology | ||||||
| 09/06/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Dermatology | ||||||
| 08/22/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Immunology | ||||||
| 08/22/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological), NUCALA | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: IMMUNOLOGY | ||||||
| 08/15/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Dermatology | ||||||
| 07/19/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: KRYSTEXXA | ||||||
| 07/18/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Bone Health | ||||||
| 07/18/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Bone Health | ||||||
| 07/06/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $28.70 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 14 | 48 | $8,448 | $4,488 |
| 2022 | 1 | 12 | 12 | $2,760 | $1,440 |
Total Patients
26
Total Services
60
Medicare Billing
$5,928
Procedure Codes
2
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 48 | $8,448 | $4,488 | 53.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $2,760 | $1,440 | 52.2% |
About Dr. Zabeth Cure Lopez, M.D
Dr. Zabeth Cure Lopez, M.D is a Rheumatology healthcare provider based in Palm Springs, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/30/2012. The National Provider Identifier (NPI) number assigned to this provider is 1467728733.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Zabeth Cure Lopez, M.D has received a total of $8,417 in payments from pharmaceutical and medical device companies, with $374.12 received in 2024. These payments were reported across 374 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($8,343).
As a Medicare-enrolled provider, Cure Lopez has provided services to 26 Medicare beneficiaries, totaling 60 services with total Medicare billing of $5,928. Data is available for 2 years (2022–2023), covering 2 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Palm Springs, FL
- Active Since 03/30/2012
- Last Updated 03/16/2021
- Taxonomy Code 207RR0500X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1467728733
Products in Payments
- COSENTYX (Biological) $738.41
- Cimzia (Drug) $633.03
- Humira (Biological) $592.77
- Tymlos (Biological) $538.35
- Enbrel (Biological) $405.47
- ORENCIA (Biological) $344.98
- ACTHAR (Biological) $312.06
- Rituxan (Biological) $298.98
- TALTZ (Drug) $273.72
- KEVZARA (Drug) $269.65
- EVENITY (Biological) $268.51
- BENLYSTA (Biological) $260.02
- Prolia (Biological) $255.76
- XIFAXAN (Drug) $197.85
- SAPHNELO (Biological) $157.65
- KRYSTEXXA (Biological) $145.13
- XELJANZ (Drug) $142.79
- FORTEO (Drug) $136.95
- Rasuvo (Drug) $133.85
- KRYSTEXXA (Drug) $132.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.